Nicholas Haft

Insider Reports History

Entity
Individual
Location
C/O Finch Therapeutics Group, Inc., 200 Inner Belt Road, Suite 400, Somerville, MA
Signature
By: /s/ Matthew P. Blischak, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nicholas Haft:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Finch Therapeutics Group, Inc. Director Stock Option (right to buy) 10K Jun 8, 2023 Direct

Insider Reports Filed by Nicholas Haft

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FNCH Finch Therapeutics Group, Inc. Jun 8, 2023 1 $0 4 Jun 9, 2023 Director
FNCH Finch Therapeutics Group, Inc. Jun 13, 2022 1 $0 4 Jun 15, 2022 Director
FNCH Finch Therapeutics Group, Inc. Dec 20, 2021 1 $650K 4 Dec 22, 2021 Director